KMB vs TRVI · P/E 19, rev $8.35B vs $2.32B cap
Kimberly-Clark Corporation (KMB) versus Trevi Therapeutics Inc (TRVI) — a side-by-side from cached financials, not a winner call.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Trevi Therapeutics Inc (TRVI) is a biotechnology company listed on NASDAQ.
Latest reported KMB revenue for 2026-06-30 was $8.35B. Net income was $1.01B. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
TRVI does not have a complete income-statement cache yet.
KMB currently screens at market cap $32.88B and trailing P/E 19.2. TRVI currently screens at market cap $2.32B.
Not investment advice. Open the KMB and TRVI stock pages for the full models.
Not investment advice.